Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy

被引:1
|
作者
Guerrini, Renzo [1 ]
Zaccara, Gaetano [2 ]
la Marca, Giancarlo [1 ]
Rosati, Anna [1 ]
机构
[1] Univ Florence, Childrens Hosp A Meyer, Paediat Neurol Unit & Labs, I-50139 Florence, Italy
[2] San Giovanni Dio Hosp, Neurol Unit, Florence, Italy
关键词
TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; REFRACTORY PARTIAL SEIZURES; LONG-TERM SAFETY; ADD-ON THERAPY; NEGATIVE MYOCLONUS; DOUBLE-BLIND; TOPIRAMATE; VIGABATRIN; FELBAMATE;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of treating epilepsy is to control or at least decrease seizures without producing unacceptable adverse effects that impair quality of life. Antiepileptic drugs (AEDs) have been considered amongst the drugs most frequently associated with fatal suspected adverse drug reactions. Physicians must therefore be as familiar with safety and tolerability data of AEDs as they are with the expected therapeutic effects. AEDs may cause dose-related adverse effects (i.e. drowsiness, fatigue, dizziness, blurry vision and incoordination) that, in most cases, may be obviated by lowering the dosage, reducing the number of drugs or switching to a better tolerated AED. AEDs also have the potential of precipitating idiosyncratic adverse effects (i.e. serious cutaneous, haematological and hepatic events), which are more common in children and usually require withdrawal of the AED. Although occurrence of idiosyncratic adverse effects can only rarely be predicted or prevented, there are known risk factors that can help in identifying patients at high risk. Occurrence of an idiosyncratic event in a close relative, a concomitant autoimmune disease, co-treatment with specific drugs, history of a previous allergic drug reaction, starting treatment with high doses and rapid titration have all been associated with a higher risk of idiosyncratic adverse effects. New AEDs have been developed in the last two decades with the aim of improving the benefit-risk balance of AED therapy. Available evidence suggests that the newer AEDs are no more effective but may be somewhat better tolerated than older molecules. We performed a literature review with the aim of evaluating safety and tolerability of second- and third-generation AEDs in children. A PubMed search was conducted with the purpose of identifying English-language studies published between 1 January 1989 and 1 January 2011 that reported any adverse event having occurred in children with epilepsy in whom second- and third-generation AEDs were administered.
引用
收藏
页码:519 / 533
页数:15
相关论文
共 50 条
  • [21] Efficacy, safety, and tolerability of perampanel in Asian and non-Asian patients with epilepsy
    Tsai, Jing-Jane
    Ikeda, Akio
    Hong, Seung Bong
    Likasitwattanakul, Surachai
    Dash, Amitabh
    EPILEPSIA, 2019, 60 : 37 - 46
  • [22] Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs
    Rutecki, PA
    Gidal, BE
    EPILEPSY & BEHAVIOR, 2002, 3 (06) : S24 - S31
  • [23] The efficacy and safety of novel antiepileptic drugs in treatment of epilepsy of patients with brain tumors
    Zhai, Weiwei
    Yu, Qiaoling
    Wu, Huizhen
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [24] Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy
    Bruun, Emmi
    Kalviainen, Reetta
    Keranen, Tapani
    EPILEPSY RESEARCH, 2016, 127 : 60 - 65
  • [25] Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review
    Tan, Hui Jeen
    Martland, Timothy R.
    Appleton, Richard E.
    Kneen, Rachel
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2010, 19 (01): : 31 - 35
  • [26] Topiramate: A new antiepileptic drug for refractory epilepsy
    Walker, MC
    Sander, JWAS
    SEIZURE, 1996, 5 (03) : 199 - 203
  • [27] Efficacy and Tolerability of Clobazam in Adults With Drug-Refractory Epilepsy
    Jamil, Alisha
    Levinson, Noah
    Gelfand, Michael
    Hill, Chloe E.
    Khankhanian, Pouya
    Davis, Kathryn A.
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (05) : E669 - E676
  • [28] Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy
    Kim, Hyeyun
    Kim, Dong Wook
    Lee, Soon Tae
    Byun, Jung Ick
    Seo, Jong Geun
    No, Young Joo
    Kang, Kyung Wook
    Kim, Daeyoung
    Kim, Keun Tae
    Cho, Yong Won
    Yang, Kwang Ik
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (04): : 547 - 555
  • [29] Efficacy and tolerability of levetiracetam in children with epilepsy
    Li, Jiahui
    Xiao, Nong
    Chen, Siyuan
    BRAIN & DEVELOPMENT, 2011, 33 (02): : 145 - 151
  • [30] Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician’s Overview
    Martin J Brodie
    CNS Drugs, 2017, 31 : 135 - 147